cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene

U radu će biti prikazani načini upotrebe šumske biomase (drvne tvari) u kogeneracijskim postrojenjima gdje se drvna tvar koristi kako energent njezinim sagorijevanjem ili rasplinjavanjem (pirolizom). Isto tako će biti shematski prikazana kogeneracijska postrojenja sa pojašnjenjem svih faza rada. Na kraju rada će biti prikazani primjeri kogeneracijskih postrojenja koja su u funkciji na području RH sa njihovim osnovnim karakteristikama

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments. When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments